Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 470
Filter
1.
Science ; 364(6437): 272-275, 2019 04 19.
Article in English | MEDLINE | ID: mdl-30890589

ABSTRACT

The near-Earth asteroid 162173 Ryugu, the target of the Hayabusa2 sample-return mission, is thought to be a primitive carbonaceous object. We report reflectance spectra of Ryugu's surface acquired with the Near-Infrared Spectrometer (NIRS3) on Hayabusa2, to provide direct measurements of the surface composition and geological context for the returned samples. A weak, narrow absorption feature centered at 2.72 micrometers was detected across the entire observed surface, indicating that hydroxyl (OH)-bearing minerals are ubiquitous there. The intensity of the OH feature and low albedo are similar to thermally and/or shock-metamorphosed carbonaceous chondrite meteorites. There are few variations in the OH-band position, which is consistent with Ryugu being a compositionally homogeneous rubble-pile object generated from impact fragments of an undifferentiated aqueously altered parent body.

2.
Blood Cancer J ; 7(2): e525, 2017 02 03.
Article in English | MEDLINE | ID: mdl-28157219

ABSTRACT

Primary myelofibrosis (PMF) is a myeloproliferative neoplasm that arises from clonal proliferation of hematopoietic stem cells and leads to progressive bone marrow (BM) fibrosis. While cellular mutations involved in the development of PMF have been heavily investigated, noteworthy is the important role the extracellular matrix (ECM) plays in the progression of BM fibrosis. This review surveys ECM proteins contributors of PMF, and highlights how better understanding of the control of the ECM within the BM niche may lead to combined therapeutic options in PMF.


Subject(s)
Extracellular Matrix/metabolism , Primary Myelofibrosis/genetics , Extracellular Matrix/pathology , Humans , Mutation , Primary Myelofibrosis/pathology
3.
Leukemia ; 31(1): 159-169, 2017 01.
Article in English | MEDLINE | ID: mdl-27389055

ABSTRACT

Granulocyte macrophage-colony-stimulating factor (GM-CSF) signaling regulates hematopoiesis and immune responses. CSF2RA, the gene encoding the α-subunit for GM-CSF, is significantly downregulated in t(8;21) (RUNX1-ETO or RE) leukemia patients, suggesting that it may serve as a tumor suppressor. We previously reported that GM-CSF signaling is inhibitory to RE leukemogenesis. Here we conducted gene expression profiling of primary RE hematopoietic stem/progenitor cells (HSPCs) treated with GM-CSF to elucidate the mechanisms mediating the negative effects of GM on RE leukemogenicity. We observed that GM treatment of RE HSPCs resulted in a unique gene expression profile that resembles primary human cells undergoing myelopoiesis, which was not observed in control HSPCs. Additionally, we discovered that GM-CSF signaling attenuates MYC-associated gene signatures in RE HSPCs. In agreement with this, a functional screen of a subset of GM-CSF-responsive genes demonstrated that a MYC inhibitor, MXI1 (Max interactor 1), reduced the leukemic potential of RE HSPCs and t(8;21) acute myeloid leukemia (AML) cells. Furthermore, MYC knockdown and treatment with the BET (bromodomain and extra terminal domain) inhibitor JQ1 reduced the leukemic potential of t(8;21) cell lines. Altogether, we discovered a novel molecular mechanism mediating the GM-CSF-induced reduction in leukemic potential of RE cells, and our findings support MYC inhibition as an effective strategy for reducing the leukemogenicity of t(8;21) AML.


Subject(s)
Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Hematopoietic Stem Cells/metabolism , Leukemia, Myeloid, Acute/etiology , Oncogene Proteins, Fusion/adverse effects , Proto-Oncogene Proteins c-myc/antagonists & inhibitors , Animals , Basic Helix-Loop-Helix Transcription Factors/physiology , Core Binding Factor Alpha 2 Subunit/genetics , Gene Expression Profiling , Humans , Leukemia, Myeloid, Acute/drug therapy , Leukemia, Myeloid, Acute/genetics , Mice , Myelopoiesis/genetics , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-myc/physiology , RUNX1 Translocation Partner 1 Protein , Transcription Factors/genetics , Tumor Suppressor Proteins/physiology
5.
Ann ICRP ; 45(1 Suppl): 290-6, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27012844

ABSTRACT

Current standards for radiological protection of the public have been uniformly established. However, individual differences in radiosensitivity are suggested to exist in human populations, which could be caused by nucleotide variants of DNA repair genes. In order to verify if such genetic variants are responsible for individual differences in radiosensitivity, they could be introduced into cultured human cells for evaluation. This strategy would make it possible to analyse the effect of candidate nucleotide variants on individual radiosensitivity, independent of the diverse genetic background. However, efficient gene targeting in cultured human cells is difficult due to the low frequency of homologous recombination (HR) repair. The development of artificial nucleases has enabled efficient HR-mediated genome editing to be performed in cultured human cells. A novel genome editing strategy, 'transcription activator-like effector nuclease (TALEN)-mediated two-step single base pair editing', has been developed, and this was used to introduce a nucleotide variant associated with a chromosomal instability syndrome bi-allelically into cultured human cells to demonstrate that it is the causative mutation. It is proposed that this editing technique will be useful to investigate individual radiosensitivity.


Subject(s)
Gene Editing/methods , Radiation Tolerance , Transcription Activator-Like Effector Nucleases/genetics , Humans
7.
Lett Appl Microbiol ; 59(5): 457-63, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24974946

ABSTRACT

UNLABELLED: Resistance-breaking strains of Tomato mosaic virus (ToMV) are emerging in many countries, including Japan. We examined whether deep ultraviolet (UV) irradiation on tomato plants using light-emitting diodes (LEDs) could suppress the expression of ToMV symptoms. We also investigated the optimum wavelength and radiant exposure for suppressing the disease effectively in tomato plants. Among the three wavelengths tested, UV irradiation at 280-290 nm had a relatively high suppressive effect on ToMV and resulted in a low incidence of UV damage. Pre-inoculation exposure to UV was effective in suppressing viral disease, indicating that acquired resistance was induced by UV irradiation. UV-B fluence of 0·7-1·4 kJ m(-2 ) day(-1) at wavelengths of 280-290 nm suppressed ToMV effectively without significant UV damage. SIGNIFICANCE AND IMPACT OF THE STUDY: Disease caused in tomato plants by resistance-breaking Tomato mosaic virus (ToMV) could be suppressed by ultraviolet (UV)-B irradiation using light-emitting diodes (LEDs). This paves the way for the future management of plant viral diseases using deep UV LEDs.


Subject(s)
Plant Diseases/virology , Solanum lycopersicum/virology , Tobamovirus/radiation effects , Ultraviolet Rays , Plant Diseases/therapy
8.
Br J Cancer ; 108(4): 836-47, 2013 Mar 05.
Article in English | MEDLINE | ID: mdl-23462806

ABSTRACT

BACKGROUND: Prognosis of osteosarcoma (OS) with distant metastasis and local recurrence is still poor. Y-box binding protein-1 (YB-1) is a multifunctional protein that can act as a regulator of transcription and translation and its high expression of YB-1 protein was observed in OS, however, the role of YB-1 in OS remains unclear. METHODS: Y-box binding protein-1 expression in OS cells was inhibited by specific small interfering RNAs to YB-1 (si-YB-1). The effects of si-YB-1 in cell proliferation and cell cycle transition in OS cells were analysed in vitro and in vivo. The association of nuclear expression of YB-1 and clinical prognosis was also investigated by immunohistochemistry. RESULTS: Proliferation of OS cell was suppressed by si-YB-1 in vivo and in vitro. The expression of cyclin D1 and cyclin A were also decreased by si-YB-1. In addition, si-YB-1 induced G1/S arrest with decreased cyclin D1 and cyclin A in OS cell lines. Direct binding of YB-1 in OS cell lines was also observed. Finally, the nuclear expression of YB-1 was significantly related to the poorer overall survival in OS patients. CONCLUSION: Y-box binding protein-1 would regulate cell cycle progression at G1/S and tumour growth in human OS cells in vitro and in vivo. Nuclear expression of YB-1 was closely associated with the prognosis of OS, thus, YB-1 simultaneously could be a potent molecular target and prognostic biomarker for OS.


Subject(s)
Bone Neoplasms/metabolism , Osteosarcoma/metabolism , Y-Box-Binding Protein 1/metabolism , Adolescent , Adult , Animals , Bone Neoplasms/mortality , Cell Cycle/genetics , Cell Line, Tumor , Cell Nucleus/metabolism , Cell Proliferation , Child , Cyclin A/metabolism , Cyclin D1/metabolism , Female , Humans , Male , Mice , Mice, Nude , Middle Aged , Osteosarcoma/mortality , Prognosis , RNA, Small Interfering/pharmacology , Y-Box-Binding Protein 1/antagonists & inhibitors , Y-Box-Binding Protein 1/genetics , Young Adult
9.
Eur J Med Res ; 16(12): 526-30, 2011 Dec 02.
Article in English | MEDLINE | ID: mdl-22112358

ABSTRACT

We aimed to evaluate the subcutaneous tissue reaction to a newly-developed MgO Sealer for root canals. We injected the experimental material and three existing control materials into the dorsal area of 43 male ddY mice. One week and 12 weeks after embedding, the tissue surrounding the embedding sites was removed and histopathological examination was performed. The results demonstrate that the basic histopathological reaction is the formation of fibrous capsules consisting of granulation tissue around the experimental and control embedded materials. Based on our results, we believe that the newly-developed MgO Sealer is as safe as the existing control materials and can be considered for dental use as a root canal sealer.


Subject(s)
Root Canal Filling Materials/pharmacology , Animals , Granulation Tissue/drug effects , Granulation Tissue/pathology , Magnesium Oxide/pharmacology , Male , Materials Testing , Mice , Mice, Inbred Strains , Root Canal Filling Materials/adverse effects , Subcutaneous Tissue/drug effects
10.
Eur J Med Res ; 16(7): 328-30, 2011 Jul 25.
Article in English | MEDLINE | ID: mdl-21813374

ABSTRACT

We aimed to evaluate the subcutaneous tissue reaction to a newly developed adhesive silicone denture relining material, SG, (Neo Dental Chemical Products Co., Ltd. Tokyo, Japan). We embedded the experimental material SG and another existing control material, Roeko Seal (RS), in the dorsal area of 22 male ddY mice. One week and 12 weeks after the embedding, the tissues surrounding the embedded materials were removed and a histopathological examination was performed. The results demonstrate that the basic histopathological aspects are the formation of granulation tissue and the change of the tissue to fibrous capsule over time. The results suggests that the newly-developed SG is safe as compared with the control RS, whose composition is similar.


Subject(s)
Biocompatible Materials , Denture Liners , Denture Rebasing , Granulation Tissue/pathology , Silicones , Adhesives , Animals , Male , Mice
11.
Eur J Med Res ; 16(6): 249-52, 2011 Jun 21.
Article in English | MEDLINE | ID: mdl-21810558

ABSTRACT

Polypropylene (PP), Polyethylene (PE) and polytetrafluoroethylene (FE) are high molecular materials in medical use. They are also used as the negative control materials for ISO 10993-6 international standard biological evaluation of medical devices. We examined tissue reactions to these materials embedded subcutaneously in the dorsal area of male ddY mice. One week and 12 weeks after embedding, the tissue surrounding the embedding site was removed and then histopathological examination was performed. Our results demonstrate that the basic histopathological reaction is the formation of fibrous capsule consisting of granulation tissue around the embedded materials. Based on our results, we believe that the high molecular materials such as, PP, PE and FE, can be considered for medical use as a biomaterials within the body.


Subject(s)
Biocompatible Materials/pharmacology , Polymers/pharmacology , Subcutaneous Tissue/drug effects , Animals , Biocompatible Materials/chemistry , Biocompatible Materials/toxicity , Foreign-Body Reaction/pathology , Granulation Tissue/pathology , Male , Materials Testing , Mice , Molecular Weight , Polyethylene/pharmacology , Polyethylene/toxicity , Polymers/chemistry , Polymers/toxicity , Polypropylenes/pharmacology , Polypropylenes/toxicity , Polytetrafluoroethylene/pharmacology , Polytetrafluoroethylene/toxicity , Prostheses and Implants/adverse effects , Subcutaneous Tissue/pathology
12.
Oncogene ; 30(44): 4453-63, 2011 Nov 03.
Article in English | MEDLINE | ID: mdl-21532624

ABSTRACT

Mitosis is the most conspicuous cell cycle phase, because it is the phase in which the dynamic physical distributions of cellular components into the two daughter cells occur. The separation of sister chromatids is especially important during mitosis, because of the extreme accuracy required for distribution to the next generation of cells. Shugoshin-like 1 (SGOL1) is a key protein in protecting sister chromatids from precocious separation. We have reported finding that chromosome instability is more likely in SGOL1-downregulated colorectal cancers, but it is still unknown whether there is an association between cancer and SGOL1 transcript variation. Here, we identified a novel SGOL1 variant, SGOL1-P1, in human colon cancer. The SGOL1-P1 transcript contains an exon-skip of exon 3 that results in a stop codon occurring within exon 4. Overexpression of SGOL1-P1 in HCT116 cells resulted in an increased number of cells with aberrant chromosome alignment, precociously separated chromatids and delayed mitotic progression, occasionally followed by inaccurate distribution of the chromosomes. These phenotypes, observed when SGOL1-P1 was present, were also observed very frequently in SGOL1-knockdown cells. Furthermore, the overexpression of SGOL1-P1 inhibited the localization of endogenous SGOL1 and cohesin subunit RAD21/SCC1 to the centromere. These results suggest that SGOL1-P1 may function as a negative factor to native SGOL1, and that abundant expression of SGOL1-P1 may be responsible for chromosomal instability.


Subject(s)
Alternative Splicing , Cell Cycle Proteins/genetics , Chromatids/genetics , Chromosomal Instability , Colonic Neoplasms/genetics , Mitosis , Gene Knockdown Techniques , HCT116 Cells , Humans , Protein Isoforms/metabolism , Sister Chromatid Exchange
13.
J Dent Res ; 90(6): 777-81, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21393551

ABSTRACT

The aim of the present study was to clarify the involvement of protein kinase Cγ (PKCγ) in the facial neuropathic pain following infraorbital nerve injury. We analyzed the change in PKCγ expression in the trigeminal spinal subnucleus caudalis (Vc) and upper cervical spinal cord (C1/C2) following chronic constriction injury of the infraorbital nerve (ION-CCI). We also studied ION-CCI-mediated mechanical nocifensive behavior in rats. The mechanical head-withdrawal threshold significantly decreased 1 to 14 days after ION-CCI compared with that before ION-CCI and in sham rats. The expression of PKCγ was significantly larger in the ipsilateral Vc compared with the contralateral side in ION-CCI rats 3, 7, and 14 days after ION-CCI. Intrathecal (i.t.) administration of the PKCγ inhibitor chelerythrine prevented an increase in the PKCγ expression in the ipsilateral Vc. Moreover, i.t. administration of chelerythrine annulled ION-CCI-mediated reduction in the head-withdrawal threshold. Taken together, these findings suggest that PKCγ expression in the Vc played an important role in the mechanism of orofacial static mechanical allodynia following trigeminal nerve injury.


Subject(s)
Facial Pain/enzymology , Protein Kinase C/biosynthesis , Trigeminal Caudal Nucleus/enzymology , Trigeminal Nerve Injuries , Trigeminal Neuralgia/enzymology , Animals , Behavior, Animal/drug effects , Benzophenanthridines/metabolism , Cervical Vertebrae , Constriction , Isoenzymes/biosynthesis , Male , Orbit/innervation , Protease Inhibitors/metabolism , Protein Kinase C/antagonists & inhibitors , Rats , Rats, Sprague-Dawley , Spinal Cord/enzymology
14.
Oncogene ; 28(31): 2806-20, 2009 Aug 06.
Article in English | MEDLINE | ID: mdl-19503101

ABSTRACT

BubR1 is a critical component of the mitotic checkpoint that delays the onset of anaphase until all chromosomes have established bipolar attachment to the microtubules. We previously reported that mutations of the BUB1B gene (encoding BubR1) caused premature chromatid separation (PCS) syndrome, a condition characterized by constitutional aneuploidy and a high risk of childhood cancer. We here report that the cells from PCS syndrome patients have loss of regulation of the centrosome duplication machinery, resulting in centrosome amplification and multipolar mitosis. PCS syndrome cells show increased activity of Polo-like kinase 1 (Plk1), whose knockdown suppresses centrosome amplification. BubR1 localizes to centrosomes, physically interacts with Plk1 and inhibits Plk1 phosphorylation and its kinase activity during interphase. These results unravel a crucial role of BubR1 in preventing centrosome reduplication through negative regulation of Plk1 in interphase cells.


Subject(s)
Cell Cycle Proteins/metabolism , Centrosome/metabolism , Protein Serine-Threonine Kinases/metabolism , Proto-Oncogene Proteins/metabolism , Abnormalities, Multiple/genetics , Abnormalities, Multiple/metabolism , Abnormalities, Multiple/pathology , Cell Cycle Proteins/genetics , Cell Line , Chromatids/metabolism , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , HCT116 Cells , HeLa Cells , Humans , Immunoblotting , Immunoprecipitation , Interphase , Microscopy, Fluorescence , Mutation , Phosphorylation , Protein Binding , Protein Serine-Threonine Kinases/genetics , Proto-Oncogene Proteins/genetics , RNA, Small Interfering/genetics , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Spindle Apparatus/metabolism , Syndrome , Transfection , Polo-Like Kinase 1
15.
Kyobu Geka ; 62(6): 485-7, 2009 Jun.
Article in Japanese | MEDLINE | ID: mdl-19522211

ABSTRACT

Blunt thoracic trauma rarely implicate retropharyngeal hematoma obstructing trachea. 85-year-old woman being struck on her cheek and anterior chest, visited our emergency room. She was nearly suffocated following stridor and dyspnea. Tracheal intubation relieved her dyspnea Chest computed tomography (CT) showed retropharyngeal hematoma obstructing trachea. 5 days conservative management reduced the hematoma and tracheal tube was extubated through an uneventful course.


Subject(s)
Hematoma/complications , Pharyngeal Diseases/complications , Thoracic Injuries/complications , Tracheal Stenosis/etiology , Wounds, Nonpenetrating/complications , Aged, 80 and over , Female , Humans , Tracheal Stenosis/therapy , Treatment Outcome
16.
Radiat Res ; 170(3): 345-52, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18763866

ABSTRACT

Nijmegen breakage syndrome shares several common cellular features with ataxia telangiectasia, including chromosomal instability and aberrant S- and G2-phase checkpoint regulation. We show here that after irradiation, NBS1 interacts physically with both BRCA1 and SMC1, a component of the cohesin complex, and that their interactions are completely abolished in AT cells. It is noted that BRCA1 is required for the interaction of NBS1 with SMC1, whereas the reverse is not the case, since BRCA1 is able to bind to NBS1 in the absence of an NBS1/SMC1 interaction as observed in MRE11- or RAD50-deficient cells. This indicates that ATM and BRCA1 are upstream of the NBS1/SMC1 interaction. Furthermore, the interaction of NBS1 with SMC1 requires both conserved domains of NBS in the N-terminus and the C-terminus, since they are indispensable for binding of NBS1 to BRCA1 and to MRE11/ATM, respectively. The interaction of NBS1 with SMC1 and the resulting phosphorylation are compromised in the clones lacking either the N- or C-terminus of NBS1, and as a consequence, chromatid-type aberrations are enhanced after irradiation. Our results reveal that ATM plays a fundamental role in promoting the radiation-induced interaction of NBS1 with SMC1 in the presence of BRCA1, leading to the maintenance of chromosomal integrity.


Subject(s)
Cell Cycle Proteins/metabolism , Chromatids/genetics , Chromatids/radiation effects , Chromosomal Proteins, Non-Histone/metabolism , Chromosome Aberrations , DNA-Binding Proteins/metabolism , Nuclear Proteins/metabolism , Protein Serine-Threonine Kinases/metabolism , Radiation Injuries/genetics , Signal Transduction/physiology , Tumor Suppressor Proteins/metabolism , Ataxia Telangiectasia Mutated Proteins , Cells, Cultured , Dose-Response Relationship, Radiation , Humans , Radiation Dosage , Signal Transduction/radiation effects
17.
Br J Cancer ; 98(2): 345-55, 2008 Jan 29.
Article in English | MEDLINE | ID: mdl-18195712

ABSTRACT

Glioblastoma is characterised by invasive growth and a high degree of radioresistance. Survivin, a regulator of chromosome segregation, is highly expressed and known to induce radioresistance in human gliomas. In this study, we examined the effect of survivin suppression on radiosensitivity in malignant glioma cells, while focusing on centrosome aberration and chromosome instability (CIN). We suppressed survivin by small interfering RNA transfection, and examined the radiosensitivity using a clonogenic assay and a trypan blue exclusion assay in U251MG (p53 mutant) and D54MG (p53 wild type) cells. To assess the CIN status, we determined the number of centrosomes using an immunofluorescence analysis, and the centromeric copy number by fluorescence in situ hybridisation. As a result, the radiosensitisation differed regarding the p53 status as U251MG cells quickly developed extreme centrosome amplification (=CIN) and enhanced the radiosensitivity, while centrosome amplification and radiosensitivity increased more gradually in D54MG cells. TUNEL assay showed that survivin inhibition did not lead to apoptosis after irradiation. This cell death was accompanied by an increased degree of aneuploidy, suggesting mitotic cell death. Therefore, survivin inhibition may be an attractive therapeutic target to overcome the radioresistance while, in addition, proper attention to CIN (centrosome number) is considered important for improving radiosensitivity in human glioma.


Subject(s)
Centrosome/drug effects , Chromosomal Instability/drug effects , Glioma/pathology , Microtubule-Associated Proteins/antagonists & inhibitors , Neoplasm Proteins/antagonists & inhibitors , RNA, Small Interfering/pharmacology , Radiation Tolerance/drug effects , Apoptosis/drug effects , Cell Cycle/drug effects , Cell Cycle/radiation effects , Cell Death/drug effects , Cell Death/radiation effects , Cell Line, Tumor , Cell Survival/drug effects , Cell Survival/radiation effects , Down-Regulation/drug effects , Glioma/metabolism , Humans , Inhibitor of Apoptosis Proteins , Microtubule-Associated Proteins/metabolism , Neoplasm Proteins/metabolism , Radiation-Sensitizing Agents/pharmacology , Survivin , Transfection
18.
Oncogene ; 26(41): 6002-9, 2007 Sep 06.
Article in English | MEDLINE | ID: mdl-17384674

ABSTRACT

The proteins responsible for radiation sensitive disorders, NBS1, kinase ataxia-telangiectasia-(A-T)-mutated (ATM) and MRE11, interact through the C-terminus of NBS1 in response to the generation of DNA double-strand breaks (DSBs) and are all implicated in checkpoint regulation and DSB repair, such as homologous recombination (HR). We measured the ability of several NBS1 mutant clones and A-T cells to regulate HR repair using the DR-GFP or SCneo systems. ATM deficiency did not reduce the HR repair frequency of an induced DSB, and it was confirmed by findings that HR frequencies are only slightly affected by deletion of ATM-binding site at the extreme C-terminus of NBS1. In contrast, The HR-regulating ability is dramatically reduced by deletion of the MRE11-binding domain at the C-terminus of NBS1 and markedly inhibited by mutations in the FHA/BRCT domains at the N-terminus. This impaired capability in HR is consistent with a failure to observe MRE11 foci formation. Furthermore, normal HR using sister chromatid was completely inhibited by the absence of FHA/BRCT domains. These results suggested that the N- and C-terminal domains of NBS1 are the major regulatory domains for HR pathways, very likely through the recruitment and retention of the MRE11 nuclease to DSB sites in an ATM-independent fashion.


Subject(s)
Cell Cycle Proteins/genetics , DNA Repair/genetics , DNA-Binding Proteins/genetics , Nuclear Proteins/genetics , Protein Serine-Threonine Kinases/genetics , Recombination, Genetic , Tumor Suppressor Proteins/genetics , Adenine , Ataxia Telangiectasia Mutated Proteins , DNA Breaks, Double-Stranded , Fibroblasts/physiology , Gene Frequency , Humans , Thymine
19.
Plant Dis ; 91(4): 468, 2007 Apr.
Article in English | MEDLINE | ID: mdl-30781219

ABSTRACT

The chrysanthemum (Dendranthema grandiflorum), whose planted area comprises more than 6,000 ha in Japan, is one of the most important ornamental cut flower crops. In August 2006, necrotic streaks on stems, chlorotic and necrotic spots and rings on leaves, and leaf distortions were observed on chrysanthemum cvs. Jimba and Seinotama, with a disease incidence of more than 70% (approximately 30,000 plants), which represents approximately 1,000 m2 of greenhouses of one grower in Hiroshima Prefecture, western Japan. Symptoms were similar to those caused by Tomato spotted wilt virus (TSWV) (genus Tospovirus, family Bunyaviridae). Frankliniella occidentalis was the major thrips species observed on symptomatic plants, followed by F. intonsa. Tospovirus-like spherical particles that were 80 to 100 nm in diameter were found in the infected leaves. After mechanical inoculation, a single lesion isolate reproduced the original symptoms observed in nature on healthy chrysanthemum plants (cv. Jimba). As determined by mechanical inoculation, host range and symptomatology of the isolate were similar to those described previously for Chrysanthemum stem necrosis virus (CSNV), including necrotic spots on Petunia hybrida (1). The isolate caused stunting, severe necrotic lesions on stems, necrotic spots, rings, and vein necrosis on systemically infected leaves of Lycopersicon esculentum (cv. House-momotaro). This virus reacted strongly with CSNV antiserum (DSMZ, Braunschweig, Germany) by indirect dot immuno-binding assay, and cross-reacted weakly with a monoclonal antibody to N protein of TSWV (3) using double-antibody sandwich-ELISA. Reverse transcription (RT)-PCR was conducted to verify virus infection. No amplification was observed from extracts of symptomatic plants (n = 10) by multiplex RT-PCR using TSWV and Impatiens necrotic spot virus specific primer sets (4), indicating that the diseased chrysanthemums were not doubly infected with these viruses. However, a DNA fragment of approximately 450 bp was amplified in samples by RT-PCR using tospovirus universal primers, BR60/65 (2). The nucleotide sequence of the amplified fragment had 98.1% identity with the corresponding region of the CSNV nucleocapsid protein gene (GenBank Accession No. AF067068). The above results indicate that the virus associated with a stem necrosis disease of chrysanthemums in Hiroshima is an isolate of CSNV. To our knowledge, this is the first report of CSNV in Japan. References: (1) I. C. Bezerra et al. Phytopathology 89:823, 1999. (2) M. Eiras et al. Fitopatol. Bras. 26:170, 2001. (3) S. Tsuda et al. Ann. Phytopathol. Soc. Jpn. 60:216, 1994. (4) H. Uga and S. Tsuda. Phytopathology 95:166, 2005.

20.
Genome Dyn ; 1: 191-205, 2006.
Article in English | MEDLINE | ID: mdl-18724061

ABSTRACT

Nijmegen breakage syndrome (NBS) is a rare recessive genetic disorder, characterized by bird-like facial appearance, early growth retardation, congenital microcephaly, immunodeficiency and high frequency of malignancies. NBS belongs to the so-called chromosome instability syndromes; in fact, NBS cells display spontaneous chromosomal aberrations and are hypersensitive to DNA double-strand break-inducing agents, such as ionizing radiations. NBS1, the gene underlying the disease, is located on human chromosome 8q21. The disease appears to be prevalent in the Eastern and Central European population where more than 90% of patients are homozygous for the founder mutation 657del5 leading to a truncated variant of the protein. NBS1 forms a multimeric complex with MRE11/RAD50 nuclease at the C-terminus and retains or recruits them at the vicinity of sites of DNA damage by direct binding to histone H2AX, which is phosphorylated by PI3-kinase family, such as ATM, in response to DNA damage. Thereafter, the NBS1-complex proceeds to rejoin double-strand breaks predominantly by homologous recombination repair in vertebrates. NBS cells also show to be defective in the activation of intra-S phase checkpoint. We review here some cellular and molecular aspects of NBS, which might contribute to the clinical symptoms of the disease.


Subject(s)
Cell Cycle Proteins/genetics , Nijmegen Breakage Syndrome/genetics , Nuclear Proteins/genetics , Cell Cycle , Chromosomal Instability , DNA Damage , DNA Repair , Founder Effect , Histones/metabolism , Homozygote , Humans , Models, Biological , Models, Genetic , Phosphatidylinositol 3-Kinases/metabolism , Phosphorylation , White People
SELECTION OF CITATIONS
SEARCH DETAIL
...